Across TCGA patient cohorts, KRT16P2 mutation is significantly associated with the RNA expression of many other genes, with 198 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible KRT16P2-associated genes across cancer lineages are TAS2R7, RNA5SP369, and RNU6-6P. Each is linked with KRT16P2 in more than 1 cancer types. Because this analysis shows association rather than direction, both KRT16P2-to-partner and partner-to-KRT16P2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (KRT16P2→partner) and Y-score (partner→KRT16P2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CESC	TAS2R7 →	+0.050	+5.144	<.001	.003	3	2
CESC	RNA5SP369 →	+0.341	+4.539	<.001	.008	3	2
UCEC	RNU6-6P →	+0.902	+2.714	<.001	.004	3	2
BRCA	MIR4436B1 →	+0.149	+7.057	<.001	.009	3	2
BRCA	CYCSP46 →	+0.118	+4.386	<.001	.008	3	2
SKCM	PEX5L-AS2 →	+0.313	+3.521	<.001	.002	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 198 associations by consensus.

Exploration

KRT16P2 survival (RNA) · tumor vs normal (RNA) · all KRT16P2 data types